Filing Details
- Accession Number:
- 0001437749-25-023961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-30 16:02:05
- Reporting Period:
- 2025-07-28
- Filing Date:
- 2025-07-30
- Accepted Time:
- 2025-07-30 16:02:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763581 | Mark Schoenberg | 400 Alexander Park Drive Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 5,149 shares | Avg. Price: $19.14 | Total Value: $98,551.86 |
| Number of Shares After Transactions: | 158,229 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-07-28 | 10,000 | $0.00 | 163,378 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-07-28 | 5,149 | $19.14 | 158,229 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event.
- Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
- Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units.
Billionaire Hedge Funds
